Preliminary experience with dosimetry, response and patient reported outcome after 177Lu-PSMA-617 therapy for metastatic castration-resistant prostate cancer
暂无分享,去创建一个
G. Böning | C. Stief | P. Bartenstein | A. Rominger | F. Gildehaus | C. Gratzke | S. Lehner | W. Fendler | Andreas Delker | H. Ilhan | S. Reinhardt | Svenja Reinhardt | P. Bartenstein